Skip to main content
. 2022 Mar 7;2022:1350673. doi: 10.1155/2022/1350673

Table 2.

Survival rate of the two groups during 12 months follow-up.

Discharge 1 m 2 m 6 m 12 m
IABP group (n = 29) 19 (69.57%) 18 (60.87%) 18 (60.87%) 18 (60.87%) 17 (47.83%)
ECMO&IABP group (n = 10) 9 (90%) 9 (90%) 9 (90%) 9 (90%) 9 (90%)